Controversias sobre el uso de los agonistas beta en el tratamiento del asma aguda

This publication has 60 references indexed in Scilit:

• The use of systemic β-agonists in acute asthma in North American emergency departments
  Annals of Emergency Medicine, 1999
• In Vivo Measurements of Aerosol Dose and Distribution: Clinical Relevance
  Journal of Aerosol Medicine, 1996
• Continuous versus intermittent albuterol nebulization in the treatment of acute asthma
  Annals of Emergency Medicine, 1993
• Comparison of intermittent and continuously nebulized albuterol for treatment of asthma in an urban emergency department
  Annals of Emergency Medicine, 1993
• Comparison of nebulised aerosol deposition in the lungs of healthy adults following oral and nasal inhalation.
  Thorax, 1993
• A prospective, randomized study of continuous versus intermittent nebulized albuterol for severe status asthmaticus in children
  Critical Care Medicine, 1993
• Cardiovascular and hypokalaemic effects of inhaled salbutamol, fenoterol, and isoprenaline.
  Thorax, 1989
• Control of Asthma by Aerosols
  New England Journal of Medicine, 1986
• Hypokalemia from Beta₂-Receptor Stimulation by Circulating Epinephrine
  New England Journal of Medicine, 1983
• Optimal dose of salbutamol respiratory solution: comparison of three doses with plasma levels.
  Thorax, 1981